These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig JA, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS. Ann Intern Med; 2010 Sep 21; 153(6):358-67. PubMed ID: 20855800 [Abstract] [Full Text] [Related]
3. High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia. Low M, Lee D, Coutsouvelis J, Patil S, Opat S, Walker P, Schwarer A, Salem H, Avery S, Spencer A, Wei A. Intern Med J; 2013 Mar 21; 43(3):294-7. PubMed ID: 22757980 [Abstract] [Full Text] [Related]
5. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting. Stiff PJ, Emmanouilides C, Bensinger WI, Gentile T, Blazar B, Shea TC, Lu J, Isitt J, Cesano A, Spielberger R. J Clin Oncol; 2006 Nov 20; 24(33):5186-93. PubMed ID: 16391299 [Abstract] [Full Text] [Related]
6. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. Rosen LS, Abdi E, Davis ID, Gutheil J, Schnell FM, Zalcberg J, Cesano A, Gayko U, Chen MG, Clarke S. J Clin Oncol; 2006 Nov 20; 24(33):5194-200. PubMed ID: 17075109 [Abstract] [Full Text] [Related]
11. Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis. Schmidt E, Thoennissen NH, Rudat A, Bieker R, Schliemann C, Mesters RM, Zühlsdorf M, Müller-Tidow C, Berdel WE. Ann Oncol; 2008 Sep 20; 19(9):1644-9. PubMed ID: 18453519 [Abstract] [Full Text] [Related]
15. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. Le QT, Kim HE, Schneider CJ, Muraközy G, Skladowski K, Reinisch S, Chen Y, Hickey M, Mo M, Chen MG, Berger D, Lizambri R, Henke M. J Clin Oncol; 2011 Jul 10; 29(20):2808-14. PubMed ID: 21670453 [Abstract] [Full Text] [Related]
16. Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule. Damon LE, Johnston LJ, Ries CA, Rugo HS, Case D, Ault K, Linker CA. Cancer Chemother Pharmacol; 2004 Jun 10; 53(6):468-74. PubMed ID: 15138711 [Abstract] [Full Text] [Related]